^𝟗𝟗mTc Generator Development: Up-to-Date ^𝟗𝟗mTc Recovery Technologies for Increasing the Effectiveness of ^𝟗𝟗𝐌𝐨 Utilisation

Table 1

Current application of  ^99mTc for clinical SPECT imaging and activity dose requirement; (*) The injection activity dose (mCi ^99mTc) normally delivered in 1 mL solution of the ^99mTc-based radiopharmaceutical [167].

Organ	^99mTc radiopharmaceutical	Injection activity dose (*)	Organ	^99mTc radiopharmaceutical	Injection activity dose (*)
Brain	^99mTc-ECD	10–20 mCi	Kidney	^99mTc-MAG3	5–15 mCi
	^99mTc-ceretec (HmPAO)	10–2 mCi		^99mTc-DTPA	5–15 mCi
Lung	^99mTc-MAA	2–4 mCi		^99mTc-Gluceptate	5–15 mCi
	^99mTc-DTPA aerosol	30 mCi/3 mL; (10 mCi/mL)		^99mTc-DMSA	2–5 mCi
	^99mTc-Technegas	100–250 mCi/mL	Skeleton	^99mTc-MDP	10–20 mCi
Thyroid	^99mTc-pertechnetate	5–10 mCi		^99mTc-HDP	10–20 mCi
Liver	^99mTc-IDA	5–10 mCi	Heart	^99mTc-Sestamibi	10–30 mCi
	^99mTc-sulfur/albumine colloid	5–15 mCi		^99mTc-PYP	10–15 mCi
Spleen	^99mTc-sulfur/albumine colloid	2-3 mCi		^99mTc-Tetrofosmin	5–25 mCi
	^99mTc-red blood cells	2-3 mCi	Tumour	^99mTc-Sestamibi	15–20 mCi